Fulcrum therapeutics to host first quarter 2021 financial results conference call and webcast on thursday, may 6, 2021 at 8:00 a.m. et

Cambridge, mass., april 29, 2021 (globe newswire) -- fulcrum therapeutics, inc.  (nasdaq: fulc), a clinical-stage biopharmaceutical company focused on improving the lives of patients with genetically defined rare diseases, today announced that its first quarter 2021 financial results will be released on thursday, may 6, 2021 before the u.s. financial markets open. management will host a conference call and webcast at 8:00 a.m. et to discuss the results and provide an update on recent corporate developments.
FULC Ratings Summary
FULC Quant Ranking